Audra Riley Merck & Co., Inc.

Ms. Riley is Associate Director, Quality Systems at Merck.  Previously she worked for NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer with oversight of external quality management.  Her career includes over 23 years in engineering, quality assurance, validation, and project management at companies such as NewLink Genetics, GlaxoSmithKline, Johnson and Johnson, and Fluor Daniel. She is currently a member of the PDA Cell and Gene Therapy Task Force.